These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25516194)

  • 21. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
    Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial commentary: fluoroquinolone-resistant intestinal organisms and infections after prostate biopsy: shifting sands of the prevention narrative.
    Batura D
    Clin Infect Dis; 2015 Apr; 60(7):988-9. PubMed ID: 25516191
    [No Abstract]   [Full Text] [Related]  

  • 23. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
    Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
    Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia.
    Platell JL; Cobbold RN; Johnson JR; Trott DJ
    J Antimicrob Chemother; 2010 Sep; 65(9):1936-8. PubMed ID: 20570998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients.
    Kandemir Ö; Bozlu M; Efesoy O; Güntekin O; Tek M; Akbay E
    J Chemother; 2016 Aug; 28(4):284-8. PubMed ID: 25630553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
    Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
    Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of fluoroquinolone-resistant Escherichia coli causing septicemic colibacillosis in calves in Italy: emergence of a multiresistant O78 clonal group.
    Marchese A; Coppo E; Barbieri R; Zoppi S; Pruzzo C; Rossi F; Bergagna S; Dondo A; Debbia E
    Microb Drug Resist; 2012 Feb; 18(1):94-9. PubMed ID: 22022869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
    Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Shakil J; Piracha N; Prasad N; Kopacz J; Tarasuk A; Farrell R; Urban C; Mariano N; Wang G; Segal-Maurer S
    Urology; 2014 Apr; 83(4):710-3. PubMed ID: 24680441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
    Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
    BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis.
    van Hees BC; Tersmette M; Willems RJ; de Jong B; Biesma D; van Hannen EJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1739-44. PubMed ID: 21636586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain.
    Colomer-Lluch M; Mora A; López C; Mamani R; Dahbi G; Marzoa J; Herrera A; Viso S; Blanco JE; Blanco M; Alonso MP; Jofre J; Muniesa M; Blanco J
    J Antimicrob Chemother; 2013 Apr; 68(4):758-65. PubMed ID: 23221627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
    van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
    J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-prostate biopsy infection with Escherichia coli ST131 leading to epididymo-orchitis and meningitis caused by Gram-negative bacilli.
    Assimacopoulos A; Johnston B; Clabots C; Johnson JR
    J Clin Microbiol; 2012 Dec; 50(12):4157-9. PubMed ID: 23015671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
    Young JL; Liss MA; Szabo RJ
    Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies.
    Vigil KJ; Johnson JR; Johnston BD; Kontoyiannis DP; Mulanovich VE; Raad II; Dupont HL; Adachi JA
    Clin Infect Dis; 2010 Feb; 50(3):374-80. PubMed ID: 20038242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.
    Madigan T; Johnson JR; Clabots C; Johnston BD; Porter SB; Slater BS; Banerjee R
    Clin Infect Dis; 2015 Jul; 61(1):e5-12. PubMed ID: 25828998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Escherichia coli urinary tract infection isolates in remote northern Saskatchewan communities: the Northern Antibiotic Resistance Partnership.
    Golding GR; Persaud N; Levett PN; McDonald RR; Irvine J; Nsungu M; Woods S; Khan M; Mataseje LF; Mulvey MR;
    Diagn Microbiol Infect Dis; 2012 Nov; 74(3):242-7. PubMed ID: 22944458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.